MedTech Innovator APAC LIVE
MedTech Innovator Asia Pacific’s Webinar Live series features leading experts in medical devices, diagnostics, and digital health, sharing insights tailored to the strategic needs of our ecosystem and portfolio companies.
Each session includes panel discussions and expert commentary, addressing curated topics and questions submitted by our startups.
Webinars are streamed live on our YouTube Channel and LinkedIn, with full recordings available on this page.
2025 Webinar Schedule
*All webinars start at 10 AM SGT (GMT+8) unless otherwise noted. Webinars will be posted here, or may also be viewed on the MedTech Innovator Asia Pacific LinkedIn page.
Beyond the Pitch Deck: Crafting A One-Minute Video that Opens Door
I joined Alfaleus almost two years ago and currently serve as the Chief Operations Officer. My work focuses on managing nationwide operations, distributor coordination, and field execution for our flagship ophthalmic diagnostic product, iVA+. I graduated from Madras Christian College in 2023 and have since been actively involved in expanding our footprint across India and select international markets.
Jim is laser focused on improving the world at the intersection of health, business and technology. Currently building out the world’s biggest support ecosystem for life science startups he brings his entrepreneurial, business and engineering experience to help make the next generation of life science entrepreneurs successful.
Previously, Jim was co-founder and CEO of Clara Biotech, and also worked in consulting supporting the development of medical products from prototyping through manufacturing. He has served as lead engineer on a laser therapy device, secured 510(k) approval from the FDA for one of the first mobile medical devices and worked in all aspects of design, manufacturing, quality and regulatory.
Jim holds a bachelor’s degree in Mechanical Engineering (with honors) and a master’s degree in Bioengineering from the University of Kansas (second graduate from the program). He also holds a masters certificate in Technopreneurship (http://www.ntc.ntu.edu.sg/Pages/home.aspx) from Nanyang Technological University in Singapore.
Getting Investor-Ready: Fundraising, Term Sheets & Deal Structuring
Daniel Teo is a co-Founder & Managing Partner for Hunniwell Lake Ventures. He leads its deal sourcing & investment efforts, and serves on the Board of a number of its portfolio companies. Prior to this, he was CFO for number of startups, as well as more mature private and public companies in the various sectors including, most recently, medical devices. In these roles, he was also often leading the strategy development, corporate development and international business development efforts.
Expanding Borders: Legal Strategies for Overseas Market Entry
I am an intellectual property lawyer at Bird & Bird, based in Hong Kong, specialising in cross border and contentious IP matters in Asia Pacific, particularly for Life Sciences and Healthcare clients. My non-contentious practice covers IP portfolio management, development and implementation of IP protection strategies , regulatory advice, IP audits and clearances, transactional and licensing.
Justina Zhang (张卫华) is a Partner at Herbert Smith Freehills Kewei Joint Operation Office, advising technology clients—especially startups—on global structuring, regulatory compliance, and cross-border transactions. She helps emerging tech companies build global corporate structures that support fundraising while meeting regulatory requirements across jurisdictions.
Justina has led numerous high-profile financing and M&A deals recognized by leading legal publications. She frequently speaks on global compliance, data governance, advertising regulation, and legal risk management. She was named Outstanding Female Lawyer by ALB China and an Elite Lawyer by China Business Law Journal from 2022 to 2025.
Widely regarded as a leading lawyer in the life sciences space, Katherine Wang provides global companies and investors with cutting-edge regulatory, compliance and enforcement advice. She draws on more than 25 years of experience in the Asia-Pacific region, including five years as head of legal affairs for a global pharmaceutical company.
Multinational pharmaceutical, biotechnology and medical device clients seek Katherine’s counsel on all phases of the product life cycle, from clinical studies and market access to product manufacturing and promotion. She helps clients respond to inquiries from regulatory bodies around the world, including China’s National Medical Products Administration, the National Health Commission, the State Administration of Market Regulation, and the United States Food andDrug Administration.
In addition, Katherine routinely advises institutional and corporate investors. In this capacity, she coordinates regulatory due diligence on investment targets and prospective business partners and advises on the regulatory aspects of complex life sciences transactions. She possesses a deep understanding of the strategic and operational issues at play in Asia’s life sciences markets. Clients view Katherine as “highly professional and solutions oriented” (The Legal 500), and appreciate her ability to “provide down-to-earth legal advice” and her “good sense of business” (Chambers Greater China).
Katherine also provided counsel to academic medical centers on a variety of legal and regulatory issues associated with their cross-border research and healthcare service delivery activities. These issues include cross-border transfer of personal data and biological materials, telemedicine, remote second opinions, and patient referrals from Asia.
She is an integral member of an Asia-focused life sciences team that is consistently ranked in the top bands of Chambers Asia-Pacific Region, Chambers Greater China Region, Chambers Global and The Legal 500 China guides.
Engaging Strategics: Laying the Groundwork for Future Collaborations
Bruno Occhipinti is the CEO of Qritive, a Singapore-based start-up, developing AI-powered solutions to unlock access to fast, accurate, and affordable cancer diagnosis. Previously, he was General Manager of AICS, a venture division of ASUS enabling healthcare transformation through Artificial Intelligence. He also founded CrestaLab, a boutique consulting firm, coaching and advising corporations that enable equitable access to quality care. Formerly in Philips APAC, as Director of Strategy and New Business Development, he has designed and executed initiatives in chronic-care management, telehealth, and affordable care across Southeast Asia, after driving management consulting projects for Philips ExCo in Amsterdam as part of the Strategy Group. Prior to that, in Seoul, Bruno handled corporate development for a venture specialized in renewables within Samsung Group, after his role as Global Strategist of Samsung Group. Beforehand, he took on several roles in the software domain, as pre-sales, product manager, and consultant in Business Intelligence solutions for Hyperion (now Oracle) across APAC and Europe. He holds an MBA from Wharton and graduate degrees in International Studies, Entrepreneurship, and International Finance. He is also a certified Integral Life Coach.
Unpacking Regulatory Strategies: APAC vs U.S.
I am a Regulatory Affairs Manager at Proxima Clinical Research leading a powerhouse team of associates and specialists to research, strategize, and compose documentation to clients and FDA. I have a Masters in Biomedical Engineering from Rice University, where I am also an advisory board member for Rice 360 Institute for Global Health. As an engineer, entrepreneur, and regulatory affairs expert, I am passionate about providing innovators guidance and resources to successfully navigate the pathway to market.
Yasha Huang is currently the Head of Regulatory Policy Asia Pacific within the Global Regulatory Policy & Intelligence team at Roche Diagnostics. Prior to Roche, Yasha was most recently the Regulatory Affairs Director at APACMed, the region’s first and only MedTech industry association. Her main role was driving the regulatory initiatives for patients’ better access to medical technologies by partnering with key stakeholders including government agencies, local associations, regulatory harmonization and convergence platforms. Prior to that, she was working at the China Food and Drug Administration, where she was actively involved in global governance and stakeholder engagement, collaborating with international organizations, government agencies, NGOs, etc. Yasha holds a Master’s Degree in Public Health from Dartmouth College in U.S. She is currently the Vice Chair of Regulatory Affairs Committee (600+ members) with APACMed, providing strategic leadership to various market-based and project-based initiatives.
Daniel Moelands has accumulated 30 years of extensive experience in Regulatory Affairs, Quality, Government Affairs/Public Policy, and related functions. His global expertise lies in understanding the impact of regulations on medical devices, biologics, drugs, and combination products.
Daniel started his professional journey at the Dutch Medicines Evaluation Board after earning his pharmacy degree from Utrecht University in the Netherlands. He also completed an MBA in Pharmaceutical Business from the University of the Sciences in Philadelphia. Prior to joining Johnson and Johnson in 2020, Daniel held positions at Noven, Baxter, and Medtronic, primarily focusing on Regulatory Affairs across diverse geographies and large product portfolios. Throughout his career, he has led Regional, Franchise, and Corporate teams, demonstrating proficiency in Regulatory Operations and overseeing functional integration activities pertaining to acquisitions and significant programs, including the implementation of EU Medical Device Regulations.
Daniel is a visionary and strategic leader as well as an engaging speaker. His passion for talent development has led him to live and work in various regions, encompassing Europe, the United States, and Latin America. In January 2024, he relocated to Singapore to take on the role of leading Regulatory Affairs in the Asia-Pacific region at Johnson and Johnson MedTech.
Evidence That Matters: Running Clinical Trials, Pilots & Post Market Studies
Julien Brohan, CLP, Patent Agent, is the Director of Medtech Ventures at Cedars-Sinai Technology Ventures. He leads initiatives in venture creation, strategic investment, and industry partnerships, with a focus on medtech and digital medicine. Since joining Cedars-Sinai in 2016, Julien has advanced medical device and digital medicine technologies from early-stage development to commercialization, and today concentrates on investment activities for the institution.
Julien directs Cedars-Sinai’s investments in medtech and digital medicine startups, evaluating opportunities, conducting diligence, and supporting portfolio companies post-investment. He works closely with inventors, clinicians, industry partners, and investors to identify high-potential technologies and structure ventures positioned for growth and clinical adoption.
Prior to Cedars-Sinai, he served as a Licensing Associate at the Centre National de la Recherche Scientifique in France. He is a Certified Licensing Professional and a registered Patent Agent with the USPTO.
Joalin Lim’ career in medical technology and healthcare spans over 23+ years. Her expertise encompasses R&D, Regulatory-Quality, Clinical, Evidence-Based Marketing, Reimbursement, and Commercialization to markets in Asia & America. Joalin has led operational teams both in Asia and globally. She has seen the successful introduction of over 30 products from conception to commercialization across Asia, the America, and European markets.
Joalin has authored >50 white papers, delivered more than 80 oral presentations at conferences, and penned numerous articles in medical journals. She is currently the Founder and Group CEO of Agape-Life MedTech & Healthcare Group, offering a comprehensive suite of services ranging from strategic advisory consulting, fundraising and CRO operations to healthcare B2B e-sourcing platforms and organizing influential medical conference events. Agape-Life’s impact stretches across 18 countries in the Asia Pacific, alongside significant engagements in the Americas and the EU.
Cracking the Code: Pricing, Reimbursement & Health Economics
Dr. Pinaki Ghosh is a Health Economist with 18 years of experience in Pharmaceutical, Med Tech Industry, driving value and evidence, in EU, US and AP markets for market access.
Michelle Costa is an executive of Johnson & Johnson MedTech, currently working as the Asia Pacific, Senior Director of Health Economics Market Access. She has been working at J&J for 15 years. Her career spans commercial, access and policy with over 25 years in health economics, HTA and government reform. Michelle has worked in both pharmaceutical and MedTech sectors covering multiple medical and surgical disciplines.
PR & Brand Management
With over 25 years of international experience as a health activist, corporate affairs leader, reputation advisor, and capital connector, Jasmeet (Jasmine) Kaur has shaped reputational capital and brand equity for some of the world’s most recognised organisations across Fortune 500 companies, high-growth startups, and industry bodies. She helps purpose-led ventures in healthcare and technology earn trust, visibility, and investment. Jasmeet has led public affairs and reputation strategies for brands including Johnson & Johnson, Pfizer, Uber, Fullerton Health, Medicines Australia, Guardant Health and more. Through Kaur Advisory, she partners with purpose-driven founders and leaders to harness their voice, build visibility, and amplify their impact through tailored strategies in corporate affairs, sustainability, and leadership coaching. As a visibility coach, reputation advisor, and investor-readiness strategist, she connects high-growth ventures with capital and strategic partners, empowering founders to scale innovation with impact across the Asia Pacific.
Emma has spent almost two decades helping leading brands in the healthcare and technology sectors build their corporate reputations and trust with multiple stakeholders across Asia Pacific. Using her wealth of regional client experience, knack for storytelling and building compelling narratives combined with her integrated communication expertise, she leads the Spurwing team to develop truly impactful communications programmes for clients.
Attracting Talent and Building Effective MedTech Advisory Boards
Ajay Nair has more than 22 years’ experience in the Global Medical Device Industry, having held positions in New Product Development, Sales, Sales Education, International Marketing and Market Access, with multi-national companies (Ethicon Inc., Covidien, Eli Lilly, Medtronic) along with 10+ years of roles in leadership (General Management and Global Vice President) and increasing P&L responsibilities at Ossur and most recently WillowWood Global. Ajay’s expertise is in developing market entry strategies and leading cross-functional teams to launch products and services in target markets. His experience spans launching products in the US, EMEA and for almost 11 years within Asia Pacific inclusive of China. He now leads the international business for The Mullings Group (TMG) and is based in the Asia Pacific Region, splitting his time between Singapore and Perth, Australia. He holds a MBA in International Business and Marketing from the Thunderbird Global School of Management and a degree.
Sujit Dike serves as the CEO and is a member of the Board of Directors at Gyder Surgical.
Sujit has extensive healthcare industry experience in Orthopedics, General Surgery, Imaging, Navigation and Genomics. Prior to joining Gyder, Sujit worked at global healthcare organizations (Johnson & Johnson, Synthes), a pioneer in gene sequencing technology (Affymetrix) and a startup developing breakthrough exoskeleton technology. At Johnson & Johnson, he was Vice President of the Medtech Surgery Centers and Enabling Technologies group. His experience spans leadership roles in Account Management, Sales, Marketing, Strategy and Research & Development. In his roles, Sujit has built a track record of building high performing teams and delivering growth.
Sujit has an MBA from the Wharton School, a Masters in Biochemistry and Molecular Biology from SUNY Stony Brook and undergraduate degree in Biotechnology & Biochemical Engineering from the Indian Institute of Technology, Delhi. He is the lead and co-author of 9+ peer-reviewed publications in leading scientific journals including Nature Genetics, Genome Research and Science. And is a recipient of the US Dept of Agriculture award for significant contributions to the global rice genome sequencing initiative.
Building & Managing Sales/ Distribution Channels in APAC vs U.S.
Ajeesh has over 20 years of healthcare experience working for Johnson & Johnson in Europe and Asia Pacific. During this time he held a variety of commercial (P&L management, sales leadership, commercial excellence) and operational roles (Operations, Procurement, Finance).
Ajeesh founded Blue Box Advancements to bring commercial strategy and operations expertise to start-ups and medium sized health care firms. Blue Box’s key areas of engagement are
[1] defining commercial strategy (go to market model)
[2] operationalizing commercial model (partnerships, process, people, systems) and
[3] driving consistent sales performance (direct/ distributor).
Adam Steadman currently serves as CEO of MDD Options, a hybrid distribution and logistics organization focused on supporting start-up medical device companies as they enter commercialization in the USA. Among his previous roles, Adam was Global Head of Clinical Development for Medical Device and Diagnostics at one the world’s largest CROs, Syneos Health. In this role Adam was involved in studies conducted in many regions of the world, for a number of different regulatory pathways, for all classes of medical devices. As a subject matter expert, Adam has been involved as an author and presenter in a number of webinars, road shows, conferences and publications. Areas of expertise include clinical program development, EU MDR/IVDR and FDA IDE/NSR studies, SaMD and algorithm development. Adam has more than 18 years’ experience in Clinical Research Organizations in operations, finance and business development, prior to which time he qualified as a Chartered Accountant and held a number of leadership positions in other industries. Adam is based in the RTP area of North Carolina.